Daily omega-3 dose recommendation in the UK centres on achieving adequate intake of EPA and DHA, the long-chain omega-3 fatty acids essential for cardiovascular, neurological, and visual health. Whilst no single mandated daily amount exists, the NHS advises consuming two portions of fish weekly, including one oily fish portion, to meet baseline requirements. The European Food Safety Authority recommends 250mg combined EPA and DHA daily for general heart health, though higher doses may be appropriate for specific conditions such as hypertriglyceridaemia. Understanding optimal omega-3 intake helps support informed dietary choices and appropriate supplementation when needed.

What Is the Recommended Daily Omega-3 Dose in the UK?

In the United Kingdom, there is no single universally mandated daily omega-3 intake established by regulatory bodies. However, guidance from the Scientific Advisory Committee on Nutrition (SACN) and NHS recommendations provide practical advice. The NHS recommends that people should aim to eat two portions of fish per week, one of which should be oily fish (approximately 140g per portion), which provides a source of long-chain omega-3 fatty acids.

Omega-3 fatty acids comprise several types, but the most clinically significant are eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), both found predominantly in marine sources. A third type, alpha-linolenic acid (ALA), is plant-based but converts inefficiently to EPA (typically less than 10%) and very poorly to DHA (less than 1-5%) in the body. For general cardiovascular health maintenance, the European Food Safety Authority (EFSA) recommends a combined EPA and DHA intake of 250mg per day for adults.

It is important to note that these are baseline recommendations for healthy adults. Individual requirements may vary based on age, sex, pregnancy status, and underlying health conditions. For instance, pregnant and breastfeeding women are advised to consume oily fish but limit intake to no more than two portions weekly due to potential contaminant exposure. Those who do not consume fish may need to consider alternative sources or supplementation to meet these targets. If you are uncertain about your omega-3 needs, consult your GP or a registered dietitian for personalised advice tailored to your health profile.

How Much EPA and DHA Should You Take Daily?

The specific amounts of EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) required depend on the intended health outcome. For general maintenance of normal heart function, the EFSA recommends 250mg combined EPA and DHA daily. This modest intake supports baseline cardiovascular health and is achievable through dietary sources such as oily fish.

For individuals with elevated triglyceride levels, higher doses may be considered. According to NICE Evidence Summary (ESUOM3) on omega-3 fatty acid medicines for hypertriglyceridaemia, doses of 2–4 grams of EPA and DHA daily may help reduce triglyceride concentrations. However, routine supplementation for secondary prevention of cardiovascular events is not universally endorsed by NICE following mixed trial evidence.

DHA is important for brain and eye health, making it especially relevant during pregnancy and early development. International bodies such as EFSA and WHO suggest pregnant women consume at least 200mg of DHA daily to support foetal neurodevelopment, although UK bodies do not mandate a specific daily amount. For cognitive health in older adults, some observational studies suggest potential benefits at higher intakes, though robust clinical trial evidence remains limited and NICE does not specifically recommend omega-3 supplements for this purpose.

When selecting supplements, check the label for actual EPA and DHA content rather than total fish oil weight, as a 1000mg fish oil capsule may contain only 300mg of combined EPA and DHA. Different formulations contain varying ratios of EPA to DHA, with emerging evidence suggesting they may have different physiological effects. Always inform your GP if you are taking omega-3 supplements, particularly if you are on anticoagulant or antiplatelet medications, as high doses may increase bleeding risk.

Omega-3 Dosage for Specific Health Conditions

Omega-3 fatty acids have been studied extensively for various health conditions, and dosing recommendations differ accordingly. For hypertriglyceridaemia (elevated blood triglycerides), omega-3-acid ethyl esters are licensed in the UK at doses of 2–4 grams daily. NICE Clinical Guideline 181 advises that people with fasting triglycerides above 10 mmol/L require urgent specialist assessment, while those with persistent levels between 4.5-10 mmol/L should be considered for specialist referral.

Icosapent ethyl (a purified EPA ethyl ester) is licensed in the UK to reduce cardiovascular risk in adults with raised triglycerides (≥1.7 mmol/L) who have established cardiovascular disease and LDL-cholesterol controlled on statins, as per NICE Technology Appraisal 805. This differs from omega-3-acid ethyl esters, which are specifically licensed for hypertriglyceridaemia.

In rheumatoid arthritis, some studies have used omega-3 supplementation at doses of 2.6–3 grams of EPA and DHA daily. However, NICE guidance (NG100) does not specifically recommend omega-3 supplementation for rheumatoid arthritis, and it should not be considered a disease-modifying treatment.

For mental health conditions such as depression, the evidence is mixed. Some trials have investigated 1–2 grams of EPA daily as an adjunct to standard antidepressant therapy, though results are inconsistent. NICE guidance (NG222) does not recommend omega-3 supplements as a routine treatment for depression.

Pregnancy requires particular attention. While international bodies suggest 200–300mg of DHA daily supports foetal brain and eye development, the NHS advises pregnant women to eat no more than two portions of oily fish weekly and to avoid fish with potentially high mercury levels (shark, swordfish, marlin). For age-related macular degeneration (AMD), NICE guidance does not currently recommend omega-3 supplementation as a primary intervention. Always discuss condition-specific omega-3 use with your healthcare provider to ensure appropriateness and safety.

Food Sources vs Supplements: Meeting Your Daily Omega-3 Needs

Dietary sources of omega-3 fatty acids are generally preferred over supplements due to the additional nutritional benefits of whole foods. Oily fish remains the richest and most bioavailable source of EPA and DHA. Examples include (approximate values per 100g):

• Salmon (farmed and wild): approximately 1.5–2.5g EPA+DHA

• Mackerel: approximately 2–3g EPA+DHA

• Sardines: approximately 1.5–2g EPA+DHA

• Herring: approximately 1.5–2g EPA+DHA

• Trout: approximately 1–1.5g EPA+DHA

Consuming two portions of fish per week (140g each), including one portion of oily fish as recommended by the NHS, typically meets or exceeds the baseline omega-3 recommendations for most adults. Fresh, frozen, and canned varieties are all suitable, though canned fish in brine or water is preferable to oil-packed versions for those monitoring calorie intake.

For individuals who do not consume fish—whether due to dietary preference, allergy, or sustainability concerns—plant-based sources of ALA include flaxseeds, chia seeds, walnuts, and rapeseed oil. However, ALA conversion to EPA is inefficient and conversion to DHA is very low, so these sources alone may not provide optimal EPA and DHA status. Algae-based supplements derived from microalgae provide a direct vegetarian or vegan source of DHA and, increasingly, EPA, without reliance on fish.

Omega-3 supplements are widely available as fish oil, krill oil, cod liver oil, or algal oil capsules. When choosing a supplement, look for products that specify EPA and DHA content, are free from heavy metals and contaminants, and come from reputable UK brands compliant with food supplement regulations. Cod liver oil also contains vitamins A and D, which may contribute to excessive intake if taken alongside other supplements. If you are considering supplementation, discuss with your GP or pharmacist to ensure it aligns with your dietary intake and health needs.

Safety Considerations and Maximum Daily Omega-3 Intake

Omega-3 fatty acids are generally well tolerated, but high-dose supplementation (above 3 grams daily) may carry certain risks and should be undertaken with medical guidance. The European Food Safety Authority (EFSA) considers long-term intakes of up to 5 grams of EPA and DHA combined per day to be safe for the general adult population. However, individual tolerance and clinical context must be considered.

Common adverse effects of omega-3 supplements include gastrointestinal symptoms such as nausea, diarrhoea, fishy aftertaste, and belching. Taking supplements with meals or choosing enteric-coated formulations may reduce these effects. At very high doses (above 3–4 grams daily), there is a theoretical increased risk of bleeding, particularly in individuals taking anticoagulants (e.g., warfarin, DOACs) or antiplatelet agents (e.g., aspirin, clopidogrel). While clinically significant bleeding is rare, inform your GP if you are taking omega-3 supplements alongside these medications.

High-dose omega-3 supplementation has been associated with an increased risk of atrial fibrillation in some clinical trials, particularly at doses of 4 grams or more per day. Additionally, omega-3 supplements containing DHA may cause a modest increase in LDL cholesterol in some individuals, though pure EPA formulations (such as icosapent ethyl) typically do not have this effect. Individuals with fish or shellfish allergies should exercise caution with fish oil supplements and may prefer algae-based alternatives.

Pregnant and breastfeeding women should avoid high-dose supplements and limit oily fish intake to two portions weekly to minimise exposure to environmental contaminants such as mercury and dioxins. Cod liver oil should be avoided during pregnancy due to high vitamin A content, which may be harmful to the developing baby. If you experience unusual symptoms while taking omega-3 supplements, contact your GP promptly. Suspected side effects can be reported to the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk or via the Yellow Card app.

Frequently Asked Questions